Adverse events following immunisation with a meningococcal serogroup B vaccine: report from post-marketing surveillance, Germany, 2013 to 2016

In January 2013, a novel vaccine against Neisseria meningitidis serogroup B, the multicomponent meningococcal serogroup B vaccine (4CMenB), was approved by the European Medicines Agency. We aimed to evaluate the safety profile of this vaccine. Methods: All adverse events following immunisation (AEFI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Euro Surveill
Main Authors: Mentzer, Dirk, Oberle, Doris, Keller-Stanislawski, Brigitte
Formato: Artigo
Idioma:Inglês
Publicado em: European Centre for Disease Prevention and Control (ECDC) 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5930728/
https://ncbi.nlm.nih.gov/pubmed/29717697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2018.23.17.17-00468
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados